Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine.
from Latest Science News -- ScienceDaily https://ift.tt/oQSvC4K
0 Comments